SARS-CoV-2 recurrence and probable reinfection: outcome of a descriptive surveillance in a Nigerian tertiary hospital

Authors

  • Datonye Dennis Alasia Department of Medicine, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria http://orcid.org/0000-0002-2873-8651
  • Omosivie Maduka Department of Preventive and Social Medicine, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria
  • Kennedy Wariso Department of Medical Microbiology, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria
  • Temitayo Awopeju Department of Medical Microbiology, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria
  • Faith Emuh Department of Medical Microbiology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

DOI:

https://doi.org/10.18203/2320-6012.ijrms20211912

Keywords:

SARS-CoV-2, COVID-19, Reinfection, Recurrence, Genome sequencing, Nigeria

Abstract

Background: The reports of SARS-CoV-2 reinfection have increased. This stimulates the need for surveillance in diverse populations to establish the extent of reinfections and the challenges to diagnosis.

Methods: A retrospective descriptive survey aimed at identifying probable SARS-CoV-2 reinfections using established criteria and proposed definitions was performed at a tertiary hospital in South-South, Nigeria.

Results: The study found two cases for evaluation of reinfection. One case was identified as probable reinfection, pending the outcome of gene sequencing, while the second case was categorized as recurrence. The limited access to routine genetic sequencing for confirmation of reinfection was identified as a key challenge.

Conclusions: Probable SARS-CoV-2 reinfections occur in Nigeria. Systematic surveillance of SARS-CoV-2 testing at the state and country-level is advocated to have a more accurate estimate of the burden of reinfections in the country. Access to genetic sequencing should be scaled up in Nigeria.

 

Metrics

Metrics Loading ...

Author Biographies

Datonye Dennis Alasia, Department of Medicine, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria

A senior lecturer in Internal Medicine and Consultant Physician & Head of Respiratory and Infectious disease Unit

Omosivie Maduka, Department of Preventive and Social Medicine, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria

Department of Preventive and Social Medicine, Senior Lecturer

Kennedy Wariso, Department of Medical Microbiology, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria

Department of Medical Microbiology, Professor

Temitayo Awopeju, Department of Medical Microbiology, University of Port Harcourt, College of Health Sciences, Port Harcourt, Nigeria

Department of Medical Microbiology, Senior Lecturer

Faith Emuh, Department of Medical Microbiology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

Department of Medical Microbiology

References

UNICEF. The evolving epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young people. UNICEF Office of Research, 2020. Available at: https://www.unicef-irc.org/publications/pdf/Evolving-Epidemiologic-Clinical-Picture-SARS-CoV2-COVID-19-Children-Young-People.pdf. Accessed on 17 September 2020.

Kirkcaldy RD, King BA, Brooks JT. COVID-19 and post-infection immunity: limited evidence, many remaining questions. JAMA. 2020;323(22):2245-6.

Edridge AWD, Kaczorowska J, Hoste ACR, Bakker M, Klein M, Jebbink MF, et al. Human coronavirus reinfection dynamics: lessons for SARS‐CoV‐2. MedRxiv. 2020.

Roy S. COVID-19 reinfection: myth or truth? SN Compr Clin Med. 2020;29:1-4.

Duggan NM, Ludy SM, Shannon BC, Reisner AT, Wilcox SR. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results. Am J Emerg Med. 2021;39:1-3.

European Centre for Disease Prevention and Control (ECDC). Reinfection with SARS-CoV-2: considerations for public health response, 2020. https://www.ecdc.europa.eu/sites/default/files/documents/Re-infection-and-viral-shedding-threat-assessment-brief.pdf. Accessed 16 on December 2020.

Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27(3):315-8.

Chen D, Xua W, Lei Z, Huang Z, Liu J, Gao Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis. 2020;93:297-9.

Mardani M, Nadji SA, Sarhangipor KA, Sharifi-Razavi A, Baziboroun M. COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect. 2020;37:100732.

Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection. BMJ 2020;370:3340.

To KK, Hung IF, Ip JD, Chu AW, Chan WM, Tam AR, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole-genome sequencing. Clin Infect Dis. 2020:1275.

Tillett R, Sevinsky J, Hartley P, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21(1):52-8.

Larson D, Brodniak SL, Voegtly LJ, Cer RZ, Glang LA, Malagon FJ, et al. A case of early reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinic Infect Dis. 2020:1436.

Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, Márquez S, Gutierrez B, Rojas-Silva P, et al. A case of SARS-CoV-2 reinfection in Ecuador. Lancet Infect Dis. 2020:1473-3099(20):30910-5.

Van-Elslande J, Vermeersch P, Vandervoort K, Wawina-Bokalanga T, Vanmechelen B, Wollants E, et al. Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain. Clin Infect Dis. 202:1330.

Selhorst P, Van-Ierssel S, Michiels J, Mariën J, Bartholomeeusen K, Dirinck E, et al. Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response. Clin Infect Dis. 2020:1850.

Mulder M, vander-Vegt DSJM, Oude-Munnink BB, GeurtsvanKessel CH, vande-Bovenkamp J, Sikkema RS, et al. Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report. Clin Infect Dis. 2020:538.

Gupta V, Bhoyar RC, Jain A, Srivastava S, Upadhayay R, Imran M, et al. Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2. Clin Infect Dis. 2020:1451.

Ozaras R, Ozdogru I, Yilmaz AA. Coronavirus disease 2019 re-infection: first report from Turkey. New Microbes New Infect. 2020;38:100774.

Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, et al. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. Clinic Infect Dis. 2020;1846.

BNO News. COVID-19 Reinfection tracker: Daily update of confirmed COVID-19 reinfections, 2021. Available at: https://bnonews.com/index.php/2020/ 08/covid-19-reinfection-tracker/. Accessed on 20 March 2020.

Babiker A, Marvil C, Waggoner JJ, Collins M, Piantadosi A. The importance and challenges of identifying SARS-CoV-2 reinfections. J Clinic Microbiol. 2021;59(4):02769-20.

Alvarez-Moreno CA, Rodríguez-Morales AJ. Testing dilemmas: post negative, positive SARS-CoV-2 RT-PCR-is it a reinfection? Travel Med Infect Dis. 2020;35:101743.

Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020;92(10):1755-6.

Xiao AT, Tong YX, Gao C. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study. J Clin Virol. 2020;127:104346.

Medscape. Fact sheet: Why the US is underestimating COVID Reinfection, 2021. Available at: https://www.medscape.com/viewarticle/945448#vp_2. Accessed on 15 March 2021

Nigerian Centre for Disease Control (NCDC). Fact sheet: COVID-19 in Nigeria: Confirmed COVID-19 cases by state, 2021. Available at: https://covid19.ncdc.gov.ng/. Accessed on 19 February 2021

Nigerian Centre for Disease Control (NCDC). Fact sheet: National Interim Guidelines for Clinical Management of COVID19. Available at: https://covid19.ncdc.gov.ng/media/files/National_Interim_Guidelines_for_Clinical_Management_of_COVID-19_v3.pdf. Accessed on 5 June 2020

Fageeh H, Alshehri A, Fageeh H, Bizzoca ME, Lo Muzio L, Quadri MFA. Re-infection of SARS-CoV-2: a case in a young dental healthcare worker. J Infect Pub Health. 2021.

deBrito CAA, Lima PMA, deBrito MCM, deOliveira DB. Second episode of COVID-19 in health professionals: report of two cases. Int Med Case Rep J. 2020:13:471-5.

Bonifácio LP, Pereira APS, Araújo CdA, Balbão VdMP, daFonseca BAL, Passos ADC, et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil. Rev Soc Bras Med Trop. 2020;53:20200619.

WHO. Fact sheet: Criteria for releasing COVID-19 patients from isolation: Coronavirus (COVID-19) Update No. 32, 2020. Available at: https://www.who.int/docs/default-source/corona viruse/risk-comms-updates/update-32-discharge-criteria.pdf?sfvrsn=3a2ceae7_6. Accessed on 10 February 2021.

Downloads

Published

2021-05-27

How to Cite

Alasia, D. D., Maduka, O., Wariso, K., Awopeju, T., & Emuh, F. (2021). SARS-CoV-2 recurrence and probable reinfection: outcome of a descriptive surveillance in a Nigerian tertiary hospital. International Journal of Research in Medical Sciences, 9(6), 1498–1508. https://doi.org/10.18203/2320-6012.ijrms20211912

Issue

Section

Original Research Articles